While one small study reports increased plasma levels of IFN-γ, IL-1β, IL-2 and TNF-α in eight PD patients24, two larger studies did not find any differences in blood and CSF levels between PD patients and healthy individuals with vs. without heterozygous GBA mutations25,26. This evidence concerns the gene IL2 and Parkinson disease.